Oncogene alterations in primary, recurrent, and metastatic human bone tumors

Franca Pompetti, Paola Rizzo, Richard M. Simon, Boris Freidlin, Daphne J. Mew, Harvey I. Pass, Piero Picci, Arthur S. Levine, Michele Carbone

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

We investigated the structure and the expression of various oncogenes in three of the most common human bone tumors-steosarcoma (36 samples from 34 patients), giant cell tumor (10 patients), and chondrosarcoma (18 patients)- in an attempt to identify the genetic alterations associated with these malignancies. Alterations of RB and p53 were detected only in osteosarcomas. Alterations of c-myc, N-myc, and c-fos were detected in osteosarcomas and giant cell tumors. Ras alterations (H-ras, Ki-ras, N-ras) were rare. Chondrosarcomas did not contain any detectable genetic alterations. Our results suggest that alterations of c-myc, N-myc, and c-fos oncogenes occur in osteosarcomas, in addition to those previously described for the tumor suppressor genes RB and p53. Moreover, statistical analyses indicate that c- fos alterations occur more frequently in osteosarcoma patients with recurrent or metastatic disease.

Original languageEnglish
Pages (from-to)37-50
Number of pages14
JournalJournal of Cellular Biochemistry
Volume63
Issue number1
DOIs
Publication statusPublished - Oct 1996

Fingerprint

Osteosarcoma
Oncogenes
Tumors
Bone
Bone and Bones
Giant Cell Tumors
Chondrosarcoma
Neoplasms
Tumor Suppressor Genes
Genes

Keywords

  • chondrosarcoma
  • GCT
  • oncogene alterations
  • osteosarcoma

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Oncogene alterations in primary, recurrent, and metastatic human bone tumors. / Pompetti, Franca; Rizzo, Paola; Simon, Richard M.; Freidlin, Boris; Mew, Daphne J.; Pass, Harvey I.; Picci, Piero; Levine, Arthur S.; Carbone, Michele.

In: Journal of Cellular Biochemistry, Vol. 63, No. 1, 10.1996, p. 37-50.

Research output: Contribution to journalArticle

Pompetti, F, Rizzo, P, Simon, RM, Freidlin, B, Mew, DJ, Pass, HI, Picci, P, Levine, AS & Carbone, M 1996, 'Oncogene alterations in primary, recurrent, and metastatic human bone tumors', Journal of Cellular Biochemistry, vol. 63, no. 1, pp. 37-50. https://doi.org/10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0
Pompetti, Franca ; Rizzo, Paola ; Simon, Richard M. ; Freidlin, Boris ; Mew, Daphne J. ; Pass, Harvey I. ; Picci, Piero ; Levine, Arthur S. ; Carbone, Michele. / Oncogene alterations in primary, recurrent, and metastatic human bone tumors. In: Journal of Cellular Biochemistry. 1996 ; Vol. 63, No. 1. pp. 37-50.
@article{5aa01e5529ed421fa0696c6495125f3f,
title = "Oncogene alterations in primary, recurrent, and metastatic human bone tumors",
abstract = "We investigated the structure and the expression of various oncogenes in three of the most common human bone tumors-steosarcoma (36 samples from 34 patients), giant cell tumor (10 patients), and chondrosarcoma (18 patients)- in an attempt to identify the genetic alterations associated with these malignancies. Alterations of RB and p53 were detected only in osteosarcomas. Alterations of c-myc, N-myc, and c-fos were detected in osteosarcomas and giant cell tumors. Ras alterations (H-ras, Ki-ras, N-ras) were rare. Chondrosarcomas did not contain any detectable genetic alterations. Our results suggest that alterations of c-myc, N-myc, and c-fos oncogenes occur in osteosarcomas, in addition to those previously described for the tumor suppressor genes RB and p53. Moreover, statistical analyses indicate that c- fos alterations occur more frequently in osteosarcoma patients with recurrent or metastatic disease.",
keywords = "chondrosarcoma, GCT, oncogene alterations, osteosarcoma",
author = "Franca Pompetti and Paola Rizzo and Simon, {Richard M.} and Boris Freidlin and Mew, {Daphne J.} and Pass, {Harvey I.} and Piero Picci and Levine, {Arthur S.} and Michele Carbone",
year = "1996",
month = "10",
doi = "10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0",
language = "English",
volume = "63",
pages = "37--50",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Oncogene alterations in primary, recurrent, and metastatic human bone tumors

AU - Pompetti, Franca

AU - Rizzo, Paola

AU - Simon, Richard M.

AU - Freidlin, Boris

AU - Mew, Daphne J.

AU - Pass, Harvey I.

AU - Picci, Piero

AU - Levine, Arthur S.

AU - Carbone, Michele

PY - 1996/10

Y1 - 1996/10

N2 - We investigated the structure and the expression of various oncogenes in three of the most common human bone tumors-steosarcoma (36 samples from 34 patients), giant cell tumor (10 patients), and chondrosarcoma (18 patients)- in an attempt to identify the genetic alterations associated with these malignancies. Alterations of RB and p53 were detected only in osteosarcomas. Alterations of c-myc, N-myc, and c-fos were detected in osteosarcomas and giant cell tumors. Ras alterations (H-ras, Ki-ras, N-ras) were rare. Chondrosarcomas did not contain any detectable genetic alterations. Our results suggest that alterations of c-myc, N-myc, and c-fos oncogenes occur in osteosarcomas, in addition to those previously described for the tumor suppressor genes RB and p53. Moreover, statistical analyses indicate that c- fos alterations occur more frequently in osteosarcoma patients with recurrent or metastatic disease.

AB - We investigated the structure and the expression of various oncogenes in three of the most common human bone tumors-steosarcoma (36 samples from 34 patients), giant cell tumor (10 patients), and chondrosarcoma (18 patients)- in an attempt to identify the genetic alterations associated with these malignancies. Alterations of RB and p53 were detected only in osteosarcomas. Alterations of c-myc, N-myc, and c-fos were detected in osteosarcomas and giant cell tumors. Ras alterations (H-ras, Ki-ras, N-ras) were rare. Chondrosarcomas did not contain any detectable genetic alterations. Our results suggest that alterations of c-myc, N-myc, and c-fos oncogenes occur in osteosarcomas, in addition to those previously described for the tumor suppressor genes RB and p53. Moreover, statistical analyses indicate that c- fos alterations occur more frequently in osteosarcoma patients with recurrent or metastatic disease.

KW - chondrosarcoma

KW - GCT

KW - oncogene alterations

KW - osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0029782691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029782691&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0

DO - 10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0

M3 - Article

VL - 63

SP - 37

EP - 50

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 1

ER -